The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
The Express Tribune on MSN
Karachi's dengue death trap fake labs, faulty tests, zero oversight
As the spread of dengue and malaria once again bedevils people in the port city, diagnostic tests and platelet treatments have become unaffordable for the public. As a result, small laboratories are ...
Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback